TIDMIDH

RNS Number : 6461E

Immunodiagnostic Systems Hldgs PLC

05 July 2019

Immunodiagnostic Systems Holdings PLC

Director Dealing

5 July 2019

Immunodiagnostic Systems Holdings PLC ("IDS") a specialist producer of manual and automated diagnostic testing kits and instruments for the clinical and research markets, announces that on 3 July 2019 it granted share options ("Options") to Paul Martin, Group Finance Director, to acquire a total of 30,000 ordinary shares of 2p each in the capital of the Company under the Company's Co-Investment Executive Share Option Scheme.

The Options have been granted with an exercise price of GBP1.80 and subject to the satisfaction of performance conditions vest after a period of 3 years. The Options are exercisable over the period of 10 years from the date of grant.

The information set out below is provided in accordance with the requirements of Article 19(3) of the EU Market Abuse Regulation No 596/2014.

For further information:

 
 Immunodiagnostic Systems Holdings     Tel : +44 (0)191 
  plc                                   519 0660 
 Paul Martin, Group Finance Director 
 
 Peel Hunt LLP                         Tel : +44 (0)207 
                                        418 8900 
 James Steel 
 Oliver Jackson

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 
 1.   Details of the person discharging managerial responsibilities 
       / person closely associated 
 a.   Name                            Paul Martin 
     ------------------------------  ---------------------------------------------- 
 2.   Reason for the notification 
     ------------------------------------------------------------------------------ 
 a.   Position/status                 Group Finance Director 
     ------------------------------  ---------------------------------------------- 
 a.   Initial notification            Initial 
       /Amendment 
     ------------------------------  ---------------------------------------------- 
 3.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
     ------------------------------------------------------------------------------ 
 a.   Name                            Immunodiagnostic Systems Holdings plc 
     ------------------------------  ---------------------------------------------- 
 b.   LEI                             213800HZMYTD4NGF4L78 
     ------------------------------  ---------------------------------------------- 
 4.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions 
       have been conducted 
     ------------------------------------------------------------------------------ 
 a.   Description                     Options over ordinary shares of 2p each 
       of the                          in Immunodiagnostic Systems Holdings plc 
       Financial instrument,           Ordinary shares 
       type                            GB00B01YZ052 
       of instrument 
       Identification 
       code 
     ------------------------------  ---------------------------------------------- 
 b.   Nature of the                   Grant of options 
       transaction 
     ------------------------------  ---------------------------------------------- 
 c.   Price(s) and                          Option   Volume(s) 
       volume(s)                           price(s) 
                                            GBP1.80      30,000 
                                                     ---------- 
     ------------------------------  ---------------------------------------------- 
 d.        Aggregated 
            information                 N/A 
             *    Aggregated volume 
 
 
             *    Price 
     ------------------------------  ---------------------------------------------- 
 e.   Date of the                     2019-07-03 
       transaction 
     ------------------------------  ---------------------------------------------- 
 f.   Place of the                    Outside trading venue - shares to be admitted 
       transaction                     to AIM market of London Stock Exchange plc 
                                       on exercise of options 
     ------------------------------  ----------------------------------------------

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHGCGDRGGGBGCU

(END) Dow Jones Newswires

July 05, 2019 05:02 ET (09:02 GMT)

Immunodiagnostic Systems (LSE:IDH)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Immunodiagnostic Systems Charts.
Immunodiagnostic Systems (LSE:IDH)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Immunodiagnostic Systems Charts.